---
title: "Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th \"Fourth Friday at Four\" Investor Webinar | ZOMDF Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278536328.md"
description: "Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th \"Fourth Friday at Four\" Investor Webinar | ZOMDF Stock News"
datetime: "2026-03-10T02:30:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278536328.md)
  - [en](https://longbridge.com/en/news/278536328.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278536328.md)
---

# Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th "Fourth Friday at Four" Investor Webinar | ZOMDF Stock News

Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th "Fourth Friday at Four" Investor Webinar | ZOMDF Stock News

### Related Stocks

- [ZOM.US](https://longbridge.com/en/quote/ZOM.US.md)
- [ZOMDF.US](https://longbridge.com/en/quote/ZOMDF.US.md)

## Related News & Research

- [05:41 ETMEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm](https://longbridge.com/en/news/282665238.md)
- [21:30 ETIBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm](https://longbridge.com/en/news/282429140.md)
- [17:26 ETImmunityBio, Inc. (IBRX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/282747624.md)
- [Key facts: BDX Q4 Revenue Misses Guidance; EVP Rick Byrd to Retire](https://longbridge.com/en/news/282383308.md)
- [Lobe Sciences launches non-brokered private placement of 14.62M shares at $0.065](https://longbridge.com/en/news/282508419.md)